Cita APA (7a ed.)
Ardakani, K. Y., Passarella, G., Lania, A. G. A., Clementi, T. D., Fanti, A., Pepe, F. F., . . . Cazzaniga, M. E. (2026). Multiple Endocrinology Immune-Related Adverse Events (irAEs) Related to Pembrolizumab as Neoadjuvant Treatment in Two Cases of TNBC Patients: Case Reports and Literature Review. Current Oncology, 31(1), 28-44.
Cita Chicago Style (17a ed.)
Ardakani, Khashayar Yazdanpanah, Gaia Passarella, Andrea Gerardo Antonio Lania, Thoma Dario Clementi, Alessandro Fanti, Francesca Fulvia Pepe, Serena Capici, y Marina Elena Cazzaniga. "Multiple Endocrinology Immune-Related Adverse Events (irAEs) Related to Pembrolizumab as Neoadjuvant Treatment in Two Cases of TNBC Patients: Case Reports and Literature Review." Current Oncology 31, no. 1 (2026): 28-44.
Cita MLA (9a ed.)
Ardakani, Khashayar Yazdanpanah, et al. "Multiple Endocrinology Immune-Related Adverse Events (irAEs) Related to Pembrolizumab as Neoadjuvant Treatment in Two Cases of TNBC Patients: Case Reports and Literature Review." Current Oncology, vol. 31, no. 1, 2026, pp. 28-44.
Precaución: Estas citas no son 100% exactas.